Is Moderna (MRNA) Quietly Redefining Its Pipeline With Canada’s Bundibugyo Ebola Trial Green Light?
In early August 2026, Well being Canada approved Moderna to start a Section I scientific trial of its Bundibugyo virus (Ebola) mRNA vaccine candidate, making Canada the second nation after the U.Okay. to clear first-in-human testing centered on security, dosing and immune response. This early-stage authorization, in an space with no licensed Bundibugyo vaccine or…